Literature DB >> 23643923

Prefrontal activation in response to emotional words in patients with bipolar disorder and major depressive disorder.

Toshio Matsubara1, Koji Matsuo, Mami Nakashima, Masayuki Nakano, Kenichiro Harada, Toshio Watanuki, Kazuteru Egashira, Yoshifumi Watanabe.   

Abstract

Abnormal emotional processing is involved in the pathophysiology of bipolar disorder (BD) and major depressive disorder (MDD). However, whether the neural mechanism underlying this deficit is a trait characteristic of BD and MDD is unclear. The aim of this study was to elucidate the similarities and differences in processing of emotional stimuli between patients with BD and MDD in remission, using functional near-infrared spectroscopy (fNIRS). Thirty-two patients (16 with BD and 16 with MDD) and 20 healthy control subjects matched for age, sex, handedness, and years of education were included. An emotional Stroop task, including happy, sad, and threat words, was used. The relative oxygenated and deoxygenated hemoglobin concentration ([oxy-Hb] and [deoxy-Hb]) changes in the frontal region were measured using 52-channels of NIRS. During the threat task, compared to healthy control subjects, patients with BD showed significantly increased [oxy-Hb] in the left inferior frontal region whereas patients with MDD showed significantly increased [oxy-Hb] in the left middle frontal region. During the happy task, compared to healthy control subjects, patients with BD showed significantly decreased [oxy-Hb] in the middle frontal region in both hemispheres. Moreover, patients with BD exhibited decreased [oxy-Hb] and increased [deoxy-Hb] in the superior frontal and middle frontal regions compared to MDD in response to the happy stimulus. No significant differences in [oxy-Hb] or [deoxy-Hb] were seen between the groups during the sad task. These results suggest that abnormal neural responses to emotional stimuli in patients with mood disorders in remission may be a trait characteristic, that negative emotional stimuli are associated with similar prefrontal responses, and that positive emotional stimuli are associated with different prefrontal responses in patients with BD and MDD. These findings indicate that different neural circuits play a role in emotional processing in BD and MDD; this may aid the elucidation of the pathophysiology of these two disorders.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emotion; Mood disorders; Near-infrared spectroscopy; Prefrontal; Stroop

Mesh:

Substances:

Year:  2013        PMID: 23643923     DOI: 10.1016/j.neuroimage.2013.04.098

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  17 in total

1.  Comparison of alterations in cerebral hemoglobin oxygenation in late life depression and Alzheimer's disease as assessed by near-infrared spectroscopy.

Authors:  Hisashi Kito; Akiko Ryokawa; Yoshihiro Kinoshita; Daimei Sasayama; Nobuhiro Sugiyama; Tomomi Ogihara; Takehiko Yasaki; Tetsuya Hagiwara; Shin Inuzuka; Tohru Takahashi; Hirokazu Genno; Hiroshi Nose; Tokiji Hanihara; Shinsuke Washizuka; Naoji Amano
Journal:  Behav Brain Funct       Date:  2014-03-17       Impact factor: 3.759

Review 2.  A Brief Review of Research Using Near-Infrared Spectroscopy to Measure Activation of the Prefrontal Cortex during Emotional Processing: The Importance of Experimental Design.

Authors:  Robert C A Bendall; Peter Eachus; Catherine Thompson
Journal:  Front Hum Neurosci       Date:  2016-10-20       Impact factor: 3.169

3.  Clinical application of DEX/CRH test and multi-channel NIRS in patients with depression.

Authors:  Shinya Kinoshita; Tetsufumi Kanazawa; Hiroki Kikuyama; Hiroshi Yoneda
Journal:  Behav Brain Funct       Date:  2016-08-31       Impact factor: 3.759

4.  Cognitive Style: Time to Experiment.

Authors:  Robert C A Bendall; Adam Galpin; Lynne P Marrow; Simon Cassidy
Journal:  Front Psychol       Date:  2016-11-15

5.  Near-Infrared Spectroscopy Reveals Abnormal Hemodynamics in the Left Dorsolateral Prefrontal Cortex of Menopausal Depression Patients.

Authors:  Xiang-Yun Ma; Yong-Jun Wang; Bo Xu; Kun Feng; Gao-Xiang Sun; Xiao-Qian Zhang; Xiao-Min Liu; Chen-Yu Shen; Xia-Jin Ren; Jing-Jing Sun; Po-Zi Liu
Journal:  Dis Markers       Date:  2017-02-14       Impact factor: 3.434

6.  Differences in frontotemporal dysfunction during social and non-social cognition tasks between patients with autism spectrum disorder and schizophrenia.

Authors:  Keiko Hirata; Kazuteru Egashira; Kenichiro Harada; Mami Nakashima; Masako Hirotsu; Shinji Isomura; Toshio Watanuki; Toshio Matsubara; Yoichi Kaku; Hiroshi Kaneyuki; Yoshifumi Watanabe; Koji Matsuo
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

7.  Diagnostic and Predictive Applications of Functional Near-Infrared Spectroscopy for Major Depressive Disorder: A Systematic Review.

Authors:  Cyrus S H Ho; Lucas J H Lim; A Q Lim; Nicole H C Chan; R S Tan; S H Lee; Roger C M Ho
Journal:  Front Psychiatry       Date:  2020-05-06       Impact factor: 4.157

8.  fNIRS Assessment during an Emotional Stroop Task among Patients with Depression: Replication and Extension.

Authors:  Yoshitaka Nishizawa; Tetsufumi Kanazawa; Yasuo Kawabata; Toshio Matsubara; Soichiro Maruyama; Makoto Kawano; Shinya Kinoshita; Jun Koh; Koji Matsuo; Hiroshi Yoneda
Journal:  Psychiatry Investig       Date:  2019-01-25       Impact factor: 2.505

9.  Abnormal prefrontal brain activation during a verbal fluency task in bipolar disorder patients with psychotic symptoms using multichannel NIRS.

Authors:  Jing-Jing Sun; Xiao-Min Liu; Chen-Yu Shen; Kun Feng; Po-Zi Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-13       Impact factor: 2.570

10.  The Mood-Improving Effect of Viewing Images of Nature and Its Neural Substrate.

Authors:  Rikuto Yamashita; Chong Chen; Toshio Matsubara; Kosuke Hagiwara; Masato Inamura; Kohei Aga; Masako Hirotsu; Tomoe Seki; Akiyo Takao; Erika Nakagawa; Ayumi Kobayashi; Yuko Fujii; Keiko Hirata; Harumi Ikei; Yoshifumi Miyazaki; Shin Nakagawa
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.